Sedan börsnoteringen fortsätter Candles att växa med ett starkt orderflöde och med miljövänliga doft...
Redeye is pleased with the news that Safello and Avanza are exploring a potential partnership.
Redeye was surprised by the strong earnings and that sales managed to hold up reasonably against str...
The essential Q3 (November-January) feedback is that the FDA process progresses without significant ...
Med distributörer och utvalda sjukhus i Europa ska 2cureX bygga en marknad för bättre cancerbehandli...
Redeye updates estimates on Aspire Global which is a now pure B2B company following the divestment o...
Redeye states that Q4 came in below estimates and that the rapid acceleration is likely pushed forwa...
Swedish Stirling förbereder sig inför kommersiell utrullning och har fått ett viktigt besked kring p...
NAGATO växte 300% 2021 Tourns omsättning i Q4'21 blev 41 mkr och växte därmed 34% y/y.
Redeye endorses 2cureX launching its third test, IndiTreat Explore, and thereby completing its portf...
Redeye retains its positive view on Speqta, currently trading below net cash.
Redeye retains its Base Case and long-term forecasts following a mixed Q4 report with strong sales a...
Fantasma Games AB (”Fantasma” eller ”Bolaget”) utvecklar och producerar spel till den globala casino...
Redeye is still optimistic on the case as the Q3 report is showing strong growth across the board.
Redeye briefly comments on Fluoguide’s directed share issue of some SEK 25m in gross proceeds, annou...
Omstrukturering i spåren av corona visar på stark tillväxt under förbättrad lönsamhet.
NoHo Partners’ February sales were over EUR 15m (earlier guided to be EUR 13-15m) while we had antic...
Raytelligence´s radarsensor eazenze har genomgått tester för godkännande av Federal Communications C...
(THIS IS A TRANSLATED VERSION OF THE SWEDISH RESEARCH UPDATE PUBLISHED 10 MARCH).
Redeye states that the Q4 report came in below estimates, but that License Sales was strong.
